These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
1053 related articles for article (PubMed ID: 15364753)
21. Discordant findings in patients with non-small-cell lung cancer: absolutely normal bone scans versus disseminated bone metastases on positron-emission tomography/computed tomography. Ak I; Sivrikoz MC; Entok E; Vardareli E Eur J Cardiothorac Surg; 2010 Apr; 37(4):792-6. PubMed ID: 20015657 [TBL] [Abstract][Full Text] [Related]
23. [Value of 18F-fluorodeoxyglucose positron emission tomography imaging in staging of non-small cell lung cancer]. Guan Y; He S; Dong J Zhonghua Yi Xue Za Zhi; 2001 Oct; 81(19):1180-3. PubMed ID: 11769705 [TBL] [Abstract][Full Text] [Related]
24. Positron emission tomography with CT in the evaluation of non-small cell lung cancer in populations with a high prevalence of tuberculosis. Low SY; Eng P; Keng GH; Ng DC Respirology; 2006 Jan; 11(1):84-9. PubMed ID: 16423207 [TBL] [Abstract][Full Text] [Related]
25. The maximum standardized uptake values on integrated FDG-PET/CT is useful in differentiating benign from malignant pulmonary nodules. Bryant AS; Cerfolio RJ Ann Thorac Surg; 2006 Sep; 82(3):1016-20. PubMed ID: 16928527 [TBL] [Abstract][Full Text] [Related]
26. The importance of 18F-FDG PET/CT, CT and X-rays in detecting primary stage III A lung cancer and the incidence of extra thoracic metastases. Sharma R; Tripathi M; D'Souza M; Jaimini A; Saw SK; Singh D; Mishra A; Mondal A Hell J Nucl Med; 2009; 12(1):22-5. PubMed ID: 19330177 [TBL] [Abstract][Full Text] [Related]
27. [Detection of unexpected extrathoracic metastases in preoperative staging of non-small-cell bronchial carcinoma (NSCLC) with positron emission tomography (PET)]. Schmid RA; Hillinger S; Bruchhaus H; Steinert HC; von Schulthess GK; Largiadèr F; Weder W Langenbecks Arch Chir Suppl Kongressbd; 1998; 115():1264-7. PubMed ID: 9931854 [TBL] [Abstract][Full Text] [Related]
28. Lymph node staging in lung cancer using [18F]FDG-PET. Halter G; Buck AK; Schirrmeister H; Aksoy E; Liewald F; Glatting G; Neumaier B; Mühling B; Nüssle-Kügele K; Hetzel M; Sunder-Plassmann L; Reske SN Thorac Cardiovasc Surg; 2004 Apr; 52(2):96-101. PubMed ID: 15103582 [TBL] [Abstract][Full Text] [Related]
29. Clinical relevance of imaging proliferative activity in lung nodules. Buck AK; Hetzel M; Schirrmeister H; Halter G; Möller P; Kratochwil C; Wahl A; Glatting G; Mottaghy FM; Mattfeldt T; Neumaier B; Reske SN Eur J Nucl Med Mol Imaging; 2005 May; 32(5):525-33. PubMed ID: 15599526 [TBL] [Abstract][Full Text] [Related]
30. [PET with (18)F-fluorodeoxyglucose for staging of non-small cell lung cancer]. Weber WA; Dietlein M; Hellwig D; Kirsch CM; Schicha H; Schwaiger M Nuklearmedizin; 2003 Aug; 42(4):135-44. PubMed ID: 12937692 [TBL] [Abstract][Full Text] [Related]
31. Preoperative staging of non-small-cell lung cancer with positron-emission tomography. Pieterman RM; van Putten JW; Meuzelaar JJ; Mooyaart EL; Vaalburg W; Koëter GH; Fidler V; Pruim J; Groen HJ N Engl J Med; 2000 Jul; 343(4):254-61. PubMed ID: 10911007 [TBL] [Abstract][Full Text] [Related]
32. FDG-PET in staging lung cancer: how does it change the algorithm? Verhagen AF; Bootsma GP; Tjan-Heijnen VC; van der Wilt GJ; Cox AL; Brouwer MH; Corstens FH; Oyen WJ Lung Cancer; 2004 May; 44(2):175-81. PubMed ID: 15084382 [TBL] [Abstract][Full Text] [Related]
33. Non-small cell lung cancer: nodal staging with FDG PET versus CT with correlative lymph node mapping and sampling. Steinert HC; Hauser M; Allemann F; Engel H; Berthold T; von Schulthess GK; Weder W Radiology; 1997 Feb; 202(2):441-6. PubMed ID: 9015071 [TBL] [Abstract][Full Text] [Related]
34. Preoperative intrathoracic lymph node staging in patients with non-small-cell lung cancer: accuracy of integrated positron emission tomography and computed tomography. Billé A; Pelosi E; Skanjeti A; Arena V; Errico L; Borasio P; Mancini M; Ardissone F Eur J Cardiothorac Surg; 2009 Sep; 36(3):440-5. PubMed ID: 19464906 [TBL] [Abstract][Full Text] [Related]
35. [Positron emission tomography for detection of lymph node metastases in lung cancer]. Sugio K; Sasaki M; Yamazaki K; Kase S; Sugimachi K Nihon Geka Gakkai Zasshi; 1999 Nov; 100(11):718-23. PubMed ID: 10629837 [TBL] [Abstract][Full Text] [Related]
36. Non-small cell lung cancer staging: efficacy comparison of integrated PET/CT versus 3.0-T whole-body MR imaging. Yi CA; Shin KM; Lee KS; Kim BT; Kim H; Kwon OJ; Choi JY; Chung MJ Radiology; 2008 Aug; 248(2):632-42. PubMed ID: 18552311 [TBL] [Abstract][Full Text] [Related]
38. Whole-body diffusion-weighted imaging vs. FDG-PET for the detection of non-small-cell lung cancer. How do they measure up? Chen W; Jian W; Li HT; Li C; Zhang YK; Xie B; Zhou DQ; Dai YM; Lin Y; Lu M; Huang XQ; Xu CX; Chen L Magn Reson Imaging; 2010 Jun; 28(5):613-20. PubMed ID: 20418042 [TBL] [Abstract][Full Text] [Related]
39. The utility of 99mTc depreotide compared with F-18 fluorodeoxyglucose positron emission tomography and surgical staging in patients with suspected non-small cell lung cancer. Kahn D; Menda Y; Kernstine K; Bushnell D; McLaughlin K; Miller S; Berbaum K Chest; 2004 Feb; 125(2):494-501. PubMed ID: 14769730 [TBL] [Abstract][Full Text] [Related]
40. Staging of non-small-cell lung cancer with integrated positron-emission tomography and computed tomography. Lardinois D; Weder W; Hany TF; Kamel EM; Korom S; Seifert B; von Schulthess GK; Steinert HC N Engl J Med; 2003 Jun; 348(25):2500-7. PubMed ID: 12815135 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]